Intuitive Surgical, Inc. (NASDAQ:ISRG) Given Consensus Rating of “Moderate Buy” by Analysts

Intuitive Surgical, Inc. (NASDAQ:ISRG) has received an average recommendation of “Moderate Buy” from the twenty-nine analysts that are covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, seven have issued a hold rating, nineteen have issued a buy rating and two have issued a strong buy rating on the company. The average 1-year price objective among brokerages that have updated their coverage on the stock in the last year is $608.9231.

Several equities research analysts have recently commented on the stock. Evercore ISI upped their price target on shares of Intuitive Surgical from $450.00 to $540.00 in a research report on Wednesday, October 22nd. BTIG Research upped their price target on shares of Intuitive Surgical from $529.00 to $589.00 and gave the company a “buy” rating in a research report on Wednesday, October 22nd. Wall Street Zen raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Sunday, October 26th. Erste Group Bank reaffirmed a “hold” rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Finally, Truist Financial set a $620.00 price target on shares of Intuitive Surgical and gave the company a “buy” rating in a research report on Wednesday, October 22nd.

Insider Buying and Selling

In related news, insider Gary S. Guthart sold 2,800 shares of the stock in a transaction that occurred on Friday, October 24th. The shares were sold at an average price of $546.27, for a total value of $1,529,556.00. Following the completion of the sale, the insider directly owned 17,120 shares of the company’s stock, valued at approximately $9,352,142.40. This represents a 14.06% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Craig H. Barratt sold 2,193 shares of the stock in a transaction that occurred on Friday, October 24th. The stock was sold at an average price of $548.01, for a total transaction of $1,201,785.93. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 96,011 shares of company stock worth $50,309,042 in the last ninety days. Corporate insiders own 0.70% of the company’s stock.

Institutional Investors Weigh In On Intuitive Surgical

Several hedge funds and other institutional investors have recently added to or reduced their stakes in ISRG. Chilton Capital Management LLC grew its holdings in Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 43 shares in the last quarter. Tobam grew its holdings in Intuitive Surgical by 666.7% during the 2nd quarter. Tobam now owns 46 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 40 shares in the last quarter. Elite Financial Inc. purchased a new stake in Intuitive Surgical during the 1st quarter valued at approximately $26,000. Kilter Group LLC purchased a new stake in Intuitive Surgical during the 2nd quarter valued at approximately $27,000. Finally, LFA Lugano Financial Advisors SA purchased a new stake in Intuitive Surgical during the 1st quarter valued at approximately $30,000. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Up 0.8%

NASDAQ ISRG opened at $534.28 on Wednesday. Intuitive Surgical has a 52 week low of $425.00 and a 52 week high of $616.00. The firm has a market capitalization of $191.53 billion, a P/E ratio of 70.67, a PEG ratio of 4.94 and a beta of 1.61. The company has a 50-day moving average price of $464.32 and a 200-day moving average price of $498.73.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. During the same quarter in the prior year, the firm earned $1.84 EPS. The business’s revenue for the quarter was up 22.9% compared to the same quarter last year. As a group, equities research analysts anticipate that Intuitive Surgical will post 6.43 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.